Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by London, G. M.
Right arrow Articles by Safar, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by London, G. M.
Right arrow Articles by Safar, M. E.
J Am Soc Nephrol 12:2759-2767, 2001
© 2001 American Society of Nephrology

Alterations of Left Ventricular Hypertrophy in and Survival of Patients Receiving Hemodialysis: Follow-up of an Interventional Study

Gérard M. London*, Bruno Pannier*, Alain P. Guerin*, Jacques Blacher{dagger}, Sylvain J. Marchais*, Bernadette Darne*, Fabien Metivier*, Hassan Adda* and Michel E. Safar{dagger}

*Service d’Hemodialyse, Hôpital F.H. Manhès, Fleury-Mérogis, and {dagger}Service de Médecine Interne, Hôpital Broussais, Paris, France.

Correspondence to Dr. Gérard M. London, Hôpital F. H. Manhes, 8 Grande Rue, Fleury-Mérogis, 91712 Cedex, France. Phone: 33169256485; Fax: 33169256525; E-mail: glondon{at}club-internet.fr

ABSTRACT. Left ventricular (LV) hypertrophy (LVH) is a risk factor for mortality in patients with end-stage renal disease (ESRD). Whether the attenuation of LVH has a positive effect on survival of patients with ESRD has not been documented. The aim of this study was to determine the effect of parallel treatment of hypertension and anemia on LV mass (LVM) and to determine the effect of LVM changes on survival. A cohort of 153 patients receiving hemodialysis was studied. The duration of follow-up was 54 ± 37 mo. All patients had echocardiographic determination of LV dimensions and LVM at baseline and regular intervals until the end of the follow-up period. During the study, BP decreased from (mean ± SD) 169.4 ± 29.7/90.2 ± 15.6 to 146.7 ± 29/78 ± 14.1 mmHg (P < 0.001), and hemoglobin increased from 8.65 ± 1.65 to 10.5 ± 1.45 g/dl (P < 0.001). The LV end-diastolic diameter and mean wall thickness decreased from 56.6 ± 6.5 to 54.8 ± 6.5 mm (P < 0.001), and from 10.4 ± 1.6 to 10.2 ± 1.6 mm (P < 0.05), respectively. The LVM decreased from 290 ± 80 to 264 ± 86 g (P < 0.01). Fifty-eight deaths occurred, 38 attributed to cardiovascular (CV) disease and 20 attributed to non-CV causes. According to Cox analyses after adjustment for age, gender, diabetes, history of CV disease, and all nonspecific CV risk factors, LVM regression positively affected the survival. The hazard risk ratio associated with a 10% LVM decrease was 0.78 (95% confidence interval, 0.63 to 0.92) for all-causes mortality and 0.72 (95% confidence interval, 0.51 to 0.90) for mortality due to CV disease. These results show that a partial LVH regression in patients with ESRD had a favorable and independent effect on patients’ all-cause and CV survival.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
A. LeBeouf, F. Mac-Way, M. S. Utescu, N. Chbinou, P. Douville, S. Desmeules, and M. Agharazii
Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform
Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3788 - 3794.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
R. K. Patel, S. Oliver, P. B. Mark, J. R. Powell, E. P. McQuarrie, J. P. Traynor, H. J. Dargie, and A. G. Jardine
Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging
Clin. J. Am. Soc. Nephrol., September 1, 2009; 4(9): 1477 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
N. C. Edwards, R. P. Steeds, P. M. Stewart, C. J. Ferro, and J. N. Townend
Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.
J. Am. Coll. Cardiol., August 4, 2009; 54(6): 505 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
K. Smith, D. Semple, S. Bhandari, and A.-M. L. Seymour
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
Eur J Heart Fail, August 1, 2009; 11(8): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
P. S. Parfrey, M. Lauve, D. Latremouille-Viau, and P. Lefebvre
Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD Patients: A Meta-Analysis
Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 755 - 762.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
R. P. Pauly, M. Copland, P. Komenda, A. Levin, A. Pierratos, and C. T. Chan
Utility and Limitations of a Multicenter Nocturnal Home Hemodialysis Cohort
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1846 - 1851.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. P. Lee, S. A. Zenios, and G. M. Chertow
Cost-Effectiveness of Frequent In-Center Hemodialysis
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1792 - 1797.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
M. M. Sood, R. P. Pauly, C. Rigatto, and P. Komenda
Left ventricular dysfunction in the haemodialysis population
NDT Plus, August 1, 2008; 1(4): 199 - 205.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. F. Culleton, M. Walsh, S. W. Klarenbach, G. Mortis, N. Scott-Douglas, R. R. Quinn, M. Tonelli, S. Donnelly, M. G. Friedrich, A. Kumar, et al.
Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial
JAMA, September 19, 2007; 298(11): 1291 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
A. S. Kliger
Frequent Nocturnal Hemodialysis A Step Forward?
JAMA, September 19, 2007; 298(11): 1331 - 1333.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
H. Thein, I. Haloob, and M. R. Marshall
Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2630 - 2639.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Hernandez, A. Gonzalez, M. Rufino, I. Laynez, A. de la Rosa, E. Porrini, J. Lacalzada, A. Barragan, V. Lorenzo, and A. Torres
Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2678 - 2685.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
F. Tentori, W. C. Hunt, M. Rohrscheib, M. Zhu, C. A. Stidley, K. Servilla, D. Miskulin, K. B. Meyer, E. J. Bedrick, H. K. Johnson, et al.
Which Targets in Clinical Practice Guidelines Are Associated with Improved Survival in a Large Dialysis Organization?
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2377 - 2384.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. Tripepi, F. A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali
Left Atrial Volume Monitoring and Cardiovascular Risk in Patients with End-Stage Renal Disease: A Prospective Cohort Study
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1316 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Portoles, J. M. Lopez-Gomez, P. Aljama, and on behalf of the MAR Study Group
A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 500 - 507.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. B. Cannata-Andia, M. Rodriguez-Garcia, N. Carrillo-Lopez, M. Naves-Diaz, and B. Diaz-Lopez
Vascular Calcifications: Pathogenesis, Management, and Impact on Clinical Outcomes
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S267 - S273.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. A. Abbas, R. I. John, M. C. Webb, M. E. Kempson, A. N. Potter, C. P. Price, S. Vickery, and E. J. Lamb
Cardiac Troponins and Renal Function in Nondialysis Patients with Chronic Kidney Disease
Clin. Chem., November 1, 2005; 51(11): 2059 - 2066.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. S. Parfrey, R. N. Foley, B. H. Wittreich, D. J. Sullivan, M. J. Zagari, D. Frei, and for the Canadian European Study
Double-Blind Comparison of Full and Partial Anemia Correction in Incident Hemodialysis Patients without Symptomatic Heart Disease
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2180 - 2189.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Yildiz, E. Memisoglu, H. Oflaz, H. Yazici, H. Pusuroglu, V. Akkaya, F. Erzengin, and S. Tepe
Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients
Nephrol. Dial. Transplant., April 1, 2005; 20(4): 760 - 767.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E. Paoletti, C. Specchia, G. Di Maio, D. Bellino, B. Damasio, P. Cassottana, and G. Cannella
The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey
Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1829 - 1834.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. P. McMahon, S. D. Roger, and A. Levin
Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney Disease
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1640 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. Zoccali, F. A. Benedetto, F. Mallamaci, G. Tripepi, G. Giacone, A. Cataliotti, G. Seminara, B. Stancanelli, and L. S. Malatino
Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis Patients
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1029 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
T. W. Doulton and G. A MacGregor
Review: Blood pressure in haemodialysis patients: The importance of the relationship between the renin-angiotensin-aldosterone system, salt intake and extracellular volume
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 14 - 22.
[Abstract] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. M. London
Cardiovascular Calcifications in Uremic Patients: Clinical Impact on Cardiovascular Function
J. Am. Soc. Nephrol., September 1, 2003; 14(90004): S305 - 309.
[Abstract] [Full Text]

Home page
 Eur Heart J SupplHome page
B. Pannier, A.P. Guerin, S.J. Marchias, and G.M. London
Benefits from angiotensin-converting enzyme inhibition in patients with renal failure: latest results
Eur. Heart J. Suppl., July 1, 2003; 5(suppl_E): E18 - E22.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. M. London, S. J. Marchais, A. P. Guerin, F. Metivier, and H. Adda
Arterial structure and function in end-stage renal disease
Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1713 - 1724.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673